Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

被引:42
|
作者
Brown, Kelly A. [1 ]
Samuel, Sharmeen [1 ]
Patel, Dilip R. [1 ]
机构
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
关键词
Attention-deficit/hyperactivity disorder (ADHD); stimulants; non-stimulant medication; methylphenidate; amphetamine; alpha-2-agonists; DEFICIT/HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; STIMULANT-DRUGS; UNITED-STATES; ADHD DRUGS; ATOMOXETINE; METHYLPHENIDATE; SAFETY; PHARMACOTHERAPY; RELEASE;
D O I
10.21037/tp.2017.08.02
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
引用
收藏
页码:36 / 47
页数:12
相关论文
共 50 条
  • [31] Psychiatric Comorbidity in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Herguner, Sabri
    Herguner, Arzu
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (02): : 114 - 118
  • [32] Sensory Processing in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Rani, Indu
    Agarwal, Vivek
    Arya, Amit
    Mahour, Pooja
    JOURNAL OF ATTENTION DISORDERS, 2023, 27 (02) : 145 - 151
  • [33] ATTENTION-DEFICIT HYPERACTIVITY DISORDER - AIDS IN CHILDREN AND ADOLESCENTS
    ALGER, I
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1989, 40 (12): : 1222 - 1223
  • [34] Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Storebo, Ole J.
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 2009 - 2010
  • [35] Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
    Li, S.
    Yu, B.
    Zhou, D.
    He, C.
    Kang, L.
    Wang, X.
    Jiang, S.
    Chen, X.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04):
  • [36] Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents
    Rizzo, Renata
    Martino, Davide
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) : 347 - 354
  • [37] Managing Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    McClain, Elizabeth K.
    Burks, Erin Jewell
    PRIMARY CARE, 2015, 42 (01): : 99 - +
  • [38] Attention-deficit/hyperactivity Disorder and Suicidality in Children and Adolescents
    Balazs, J.
    Miklosi, M.
    Kereszteny, A.
    Dallos, G.
    Gadoros, J.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [39] Attention deficit-hyperactivity disorder and enuresis in children and adolescents
    Zavadenko, N. N.
    Kolobova, N. M.
    Suvorinova, N. Yu.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (02) : 50 - 55
  • [40] Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
    Punja, Salima
    Shamseer, Larissa
    Hartling, Lisa
    Urichuk, Liana
    Vandermeer, Ben
    Nikles, Jane
    Vohra, Sunita
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):